EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 93 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,493 | -82.4% | 14,730 | -59.3% | 0.00% | – |
Q2 2023 | $25,493 | -49.8% | 36,211 | -36.1% | 0.00% | – |
Q1 2023 | $50,819 | +211.8% | 56,661 | +310.2% | 0.00% | – |
Q4 2022 | $16,299 | -90.1% | 13,813 | -47.3% | 0.00% | – |
Q2 2022 | $165,000 | -77.8% | 26,188 | -70.7% | 0.00% | – |
Q1 2022 | $742,000 | +56.5% | 89,400 | -2.0% | 0.00% | – |
Q4 2021 | $474,000 | +5.1% | 91,271 | +35.1% | 0.00% | – |
Q3 2021 | $451,000 | +295.6% | 67,563 | +501.2% | 0.00% | – |
Q4 2018 | $114,000 | – | 11,238 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 694,232 | $6,144,000 | 4.00% |
P.A.W. CAPITAL CORP | 380,000 | $3,363,000 | 2.96% |
INTERWEST VENTURE MANAGEMENT CO | 764,918 | $6,770,000 | 1.78% |
Telemetry Investments, L.L.C. | 150,477 | $1,332,000 | 1.51% |
683 Capital Management, LLC | 2,683,600 | $23,750,000 | 1.26% |
KNOTT DAVID M | 276,535 | $2,447,000 | 1.05% |
Trellus Management Company, LLC | 226,000 | $2,000,000 | 1.04% |
TOWERVIEW LLC | 140,000 | $1,239,000 | 0.77% |
Vivo Capital, LLC | 1,791,257 | $15,853,000 | 0.56% |
CAXTON CORP | 94,083 | $833,000 | 0.54% |